Products for Research Use Only
RegisterLogin

KO-947

CAT: 0804-HY-112181-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-112181-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
KO-947 is a potent and selective inhibitor of ERK1/2 kinases with potential utility in MAPK pathway dysregulated tumors.
CAS Number
1695533-89-1
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
ERK
Type
Reference compound
Related Pathways
MAPK/ERK Pathway; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/KO-947.html
Concentration
10mM
Purity
99.68
Solubility
DMSO : 62.5 mg/mL (ultrasonic)
Smiles
O=C1NC2=CC(NN=C3C4=CC=NC=C4)=C3C=C2CN1CC5=CC=CC=C5
Molecular Formula
C21H17N5O
Molecular Weight
355.39
Precautions
H302, H315, H319, H335
References & Citations
[1]Burrows F, et al. KO-947, a potent ERK inhibitor with robust preclinical single agent activity in MAPK pathway dysregulated tumors [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA) : AACR; Cancer Res 2017;77 (13 Suppl) :Abstract nr 5168. doi:10.1158/1538-7445.AM2017-5168.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Isoform
ERK1; ERK2

Related Products

CatalogName
HY-101721Ko-3290
HY-10010-01Ko 143
HY-P99406A-01Petosemtamab (FUT8-KO)
HY-P99010A-01Bemarituzumab (FUT8-KO)
HY-P99295AImgatuzumab (FUT8-KO)
HY-P9991AOsemitamab (FUT8-KO)
HY-10010RKo 143 (Standard)
HY-P99653A-01Ianalumab (FUT8-KO)
HY-P99113A-01Inebilizumab (FUT8-KO)
HY-P990902AAtigotatug (FUT8-KO)

Alternative Products

CatalogName
TQ0005-01KO-947
A19903-10KO-947 10mg
A19903-5KO-947 5mg
A19903-1KO-947 1mg
A19903-100KO-947 100mg
A19903-50KO-947 50mg
A19903-25KO-947 25mg
GTR19160639-01CI-947

Popular Products